Clinical trial

Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.

NCT01260389

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-12-01

PhaseNA

Study timeline

Study start (unknown)2010-12-01Date precision: month

Registry last updated2021-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

pharmaceutical care interventionBEHAVIORAL

Sponsors & collaborators

University Hospital, Ghentlead sponsor

University Ghentcollaborator

GlaxoSmithKlinecollaborator

Mapped research locations

GhentBelgium1 LiègeBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01260389 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.